Sensei Biotherapeutics SNSE Stock
Sensei Biotherapeutics Price Chart
Sensei Biotherapeutics SNSE Financial and Trading Overview
| Sensei Biotherapeutics stock price | 15.85 USD |
| Previous Close | 21.14 USD |
| Open | 21.14 USD |
| Bid | 19.28 USD x 100 |
| Ask | 24.15 USD x 200 |
| Day's Range | 18.32 - 21.2 USD |
| 52 Week Range | 5.6 - 36.76 USD |
| Volume | 65.22K USD |
| Avg. Volume | 61.16K USD |
| Market Cap | 26.56M USD |
| Beta (5Y Monthly) | -0.184 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -142.72 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 51.67 USD |
SNSE Valuation Measures
| Enterprise Value | -175196992 USD |
| Trailing P/E | N/A |
| Forward P/E | -4.980872 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.3429697 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.944 |
Trading Information
Sensei Biotherapeutics Stock Price History
| Beta (5Y Monthly) | -0.184 |
| 52-Week Change | 192.75% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 36.76 USD |
| 52 Week Low | 5.6 USD |
| 50-Day Moving Average | 26.29 USD |
| 200-Day Moving Average | 16 USD |
SNSE Share Statistics
| Avg. Volume (3 month) | 61.16K USD |
| Avg. Daily Volume (10-Days) | 41.91K USD |
| Shares Outstanding | 1.34M |
| Float | 811.87K |
| Short Ratio | 26.01 |
| % Held by Insiders | 30.15% |
| % Held by Institutions | 159.90% |
| Shares Short | 815.54K |
| Short % of Float | 86.42% |
| Short % of Shares Outstanding | 60.77% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -95.23% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -185506000 USD |
| Net Income Avi to Common (ttm) | -184456992 USD |
| Diluted EPS (ttm) | -142.72 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 202.79M USD |
| Total Cash Per Share (mrq) | 151.12 USD |
| Total Debt (mrq) | 1.04M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 14.393 |
| Book Value Per Share (mrq) | 14.736 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24092000 USD |
| Levered Free Cash Flow (ttm) | -92236624 USD |
Profile of Sensei Biotherapeutics
| Country | United States |
| State | MD |
| City | Rockville |
| Address | 1405 Research Boulevard |
| ZIP | 20850 |
| Phone | 240 243 8000 |
| Website | https://www.senseibio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 29 |
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Q&A For Sensei Biotherapeutics Stock
What is a current SNSE stock price?
Sensei Biotherapeutics SNSE stock price today per share is 15.85 USD.
How to purchase Sensei Biotherapeutics stock?
You can buy SNSE shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sensei Biotherapeutics?
The stock symbol or ticker of Sensei Biotherapeutics is SNSE.
Which industry does the Sensei Biotherapeutics company belong to?
The Sensei Biotherapeutics industry is Biotechnology.
How many shares does Sensei Biotherapeutics have in circulation?
The max supply of Sensei Biotherapeutics shares is 1.34M.
What is Sensei Biotherapeutics Price to Earnings Ratio (PE Ratio)?
Sensei Biotherapeutics PE Ratio is now.
What was Sensei Biotherapeutics earnings per share over the trailing 12 months (TTM)?
Sensei Biotherapeutics EPS is -142.72 USD over the trailing 12 months.
Which sector does the Sensei Biotherapeutics company belong to?
The Sensei Biotherapeutics sector is Healthcare.
Sensei Biotherapeutics SNSE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| US Tech Global Market Composite NQGM | 2296 USD — |
-1.38
|
— — | 2280.64 USD — | 2323.09 USD — | — - | — — |
| US Tech Biotechnology NBI | 5807.22 USD — |
+1.87
|
— — | 5685.34 USD — | 5809.82 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}